Benjamin Tsai Overview
- Company
- 4Tech
- Primary Position
-
Board Member
- Primary Industry
-
Healthcare
- Active Board Seats
-
7
- Med. Deal Size
-
- Med. Valuation
-
Benjamin Tsai General Information
Biography
Mr. Benjamin Tsai serves as Partner at Invus Financial Advisors. He serves as Partner at Invus Opportunities. He served as Board Member at Ablative Solutions. He serves as Board Member at ClearScore. He served as Board Member at Element Science. He serves as Board Member at Presidio Medical. He served as Partner, Invus Opportunities at The Invus Group. He serves as Board Member at Vascular Dynamics, 4Tech and Mission Lane. Previously, he was a Consultant of the Monitor Group. He holds an MBA degree from Harvard Business School and a BS degree in Business Administration from the University of Southern California.
Contact Information
Address
- Ballybrit Business Park
- Unit 3
- Galway H91 DT7C
- Ireland
Benjamin Tsai Positions (2)
| Firm name | Firm type | Title | Location | Industry | Since |
|---|---|---|---|---|---|
| Invus Financial Advisors | Investor | Partner | New York, NY | PE/Buyout | |
| Invus Opportunities | Investor | Partner | New York, NY | Venture Capital |
Benjamin Tsai Board Seats (7)
| Company | Industry | Ownership Status | Financing Status | Location | Since |
|---|---|---|---|---|---|
| 4Tech | Surgical Devices | Privately Held (backing) | Venture Capital-Backed | Galway, Ireland | |
| ClearScore Technology | Financial Software | Privately Held (backing) | Venture Capital-Backed | London, United Kingdom | |
| Element Science | Therapeutic Devices | Privately Held (backing) | Venture Capital-Backed | San Francisco, CA | |
| Mission Lane | Consumer Finance | Privately Held (backing) | Venture Capital-Backed | Atlanta, GA | |
| Oyster Point | Pharmaceuticals | Acquired/Merged (Operating Subsidiary) | Corporate Backed or Acquired | Princeton, NJ |
Benjamin Tsai Lead Partner on Deals (14)
Benjamin Tsai has been the lead partner on 14 deals. Their latest deal was with Mission Lane, a consumer finance company. The deal was made for on 13-Feb-2024.
| Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
|---|---|---|---|---|---|---|
| Mission Lane | 13-Feb-2024 | Later Stage VC | Completed | Consumer Finance | Atlanta, GA | |
| Presidio Medical | 26-Jun-2023 | Completed | Biotechnology | South San Francisco, CA | ||
| Ablative Solutions | 13-Jun-2022 | Completed | Other Devices and Supplies | Wakefield, MA | ||
| Vascular Dynamics | 02-May-2022 | Completed | Therapeutic Devices | Irvine, CA | ||
| Bolt (Financial Software) | 09-Feb-2022 | Completed | Business/Productivity Software | San Francisco, CA | ||
| Mission Lane | 26-Oct-2021 | Completed | Consumer Finance | Atlanta, GA | ||
| ClearScore Technology | 25-Jun-2021 | Completed | Financial Software | London, United Kingdom | ||
| Presidio Medical | 14-Jul-2020 | Completed | Biotechnology | South San Francisco, CA | ||
| Element Science | 03-Mar-2020 | Later Stage VC (Series C) | Completed | Therapeutic Devices | San Francisco, CA | |
| Mission Lane | 16-Sep-2019 | Early Stage VC (Series A) | Completed | Consumer Finance | Atlanta, GA |
Benjamin Tsai Network (194)
Board Members (64)
| Name | Company | Representing | Location | From |
|---|---|---|---|---|
| Donald Santel | Oyster Point | Self | Princeton, NJ | |
| Sasha Orloff | Mission Lane | Self | Atlanta, GA | |
| Vascular Dynamics | Rainbow Medical Innovation | Irvine, CA | ||
| Element Science | Self | San Francisco, CA | ||
| Vascular Dynamics | Self | Irvine, CA |
Portfolio Executives (128)
| Name | Company | Role | Deal date | Location |
|---|---|---|---|---|
| William Boland | Mission Lane | Head of Corporate Development | 13-Feb-2024 | Atlanta, GA |
| Aaron Montgomery | Mission Lane | Chief Strategy Officer | 13-Feb-2024 | Atlanta, GA |
| Mission Lane | Interim Chief Executive Officer | 13-Feb-2024 | Atlanta, GA | |
| Mission Lane | Chief Financial Officer | 13-Feb-2024 | Atlanta, GA | |
| Mission Lane | Advisor | 13-Feb-2024 | Atlanta, GA |
Fund Team Members (2)
| Name | Investor | Fund | Fund Location |
|---|---|---|---|
| Philippe Amouyal | The Invus Group | Invus Opportunities Fund | New York, NY |
| Philippe Amouyal | Invus Financial Advisors | Invus Opportunities Fund | New York, NY |
| The Invus Group | New York, NY | ||
| Invus Financial Advisors | New York, NY |
Benjamin Tsai Affiliated Funds (1)
| Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
|---|---|---|---|---|---|---|---|---|
| Invus Opportunities Fund | The Invus Group | Buyout | Closed | 2016 |
Benjamin Tsai FAQs
-
Who is Benjamin Tsai?
Mr. Benjamin Tsai serves as Partner at Invus Financial Advisors.
-
How much does Benjamin Tsai typically invest?
Benjamin Tsai's median deal size is .
-
What is Benjamin Tsai’s main position?
Benjamin Tsai’s primary position is Board Member.
-
What are the contact details for Benjamin Tsai?
Benjamin Tsai’s email address is be and his phone number is +353 (091) .
-
How many active board seats does Benjamin Tsai hold?
Benjamin Tsai holds 7 board seats including 4Tech, ClearScore Technology, Element Science, Mission Lane, and Oyster Point.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
